5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 117.60▼ | 117.59▼ | 117.59▼ | 1.32▼ | 1.18▼ |
MA10 | 59.39▼ | 59.38▼ | 59.41▼ | 1.35▼ | 0.99▲ |
MA20 | 30.28▼ | 30.32▼ | 30.40▼ | 1.23▼ | 0.78▲ |
MA50 | 12.90▼ | 12.93▼ | 12.99▼ | 1.00▲ | 0.70▲ |
MA100 | 7.12▼ | 7.15▼ | 7.06▼ | 0.79▲ | 1.12▲ |
MA200 | 4.25▼ | 4.06▼ | 3.99▼ | 0.70▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 2.338▲ | 10.042▲ | 21.236▲ | -0.023▼ | 0.073▲ |
RSI | 48.146▼ | 48.145▼ | 48.144▼ | 49.663▼ | 60.997▲ |
STOCH | 48.150 | 26.112 | 17.869▼ | 26.563 | 48.978 |
WILL %R | -99.998▼ | -99.998▼ | -99.998▼ | -99.973▼ | -99.879▼ |
CCI | -35.904 | -35.923 | -36.006 | 466.667▲ | 466.667▲ |
Thursday, May 15, 2025 05:00 PM
SILICON VALLEY, CA - May 14, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system ...
|
Friday, May 09, 2025 06:12 AM
This comprehensive patent coverage reinforces ABVC's international strategy to ultimately commercialize its botanical CNS pipeline in the most strategically important pharmaceutical markets.
|
Friday, May 09, 2025 06:00 AM
ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system (CNS), ophthalmology, and oncology/hematology ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
22/05/25 | 1.17 | 583.26 | 1.165 | 1.165 | 116,409 |
21/05/25 | 1.32 | 1.36 | 1.15 | 1.19 | 460,304 |
20/05/25 | 1.40 | 1.41 | 1.30 | 1.37 | 208,012 |
19/05/25 | 1.52 | 1.52 | 1.345 | 1.38 | 223,408 |
16/05/25 | 1.26 | 1.50 | 1.26 | 1.48 | 471,473 |
15/05/25 | 1.47 | 1.4799 | 1.14 | 1.21 | 448,453 |
14/05/25 | 1.70 | 1.79 | 1.41 | 1.46 | 632,139 |
13/05/25 | 1.38 | 1.68 | 1.38 | 1.68 | 704,746 |
12/05/25 | 1.35 | 1.42 | 1.30 | 1.36 | 406,245 |
09/05/25 | 1.32 | 1.35 | 1.18 | 1.21 | 294,890 |
|
|
||||
|
|
||||
|
|